A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2014-10-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2014.09.087PMID 25264200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10

  2013cited by this paper
• Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds

  2013cited by this paper
• Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study

  2012cited by this paper
• Detection of cytoplasmic nucleophosmin expression by imaging flow cytometry

  2012cited by this paper
• An SMN-dependent U12 splicing event essential for motor circuit function.

  2012cited by this paper
• Utility of Survival Motor Neuron ELISA for Spinal Muscular Atrophy Clinical and Preclinical Analyses

  2011cited by this paper
• Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy

  2011cited by this paper
• Antisense oligonucleotides and spinal muscular atrophy: skipping along.

  2010cited by this paper
• PML protein analysis using imaging flow cytometry

  2010cited by this paper
• Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.

  2010cited by this paper
• Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid

  2010cited by this paper
• Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

  2009cited by this paper
• Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy

  2009cited by this paper
• Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.

  2008cited by this paper
• A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy

  2008cited by this paper
• The neurologist as expert witness.

  2006cited by this paper
• SMN mRNA and protein levels in peripheral blood

  2006cited by this paper
• A novel cell immunoassay to measure survival of motor neurons protein in blood cells

  2006cited by this paper
• Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.

  2003cited by this paper
• The molecular bases of spinal muscular atrophy.

  2002cited by this paper
• A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.

  1999cited by this paper
• Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues.

  1998cited by this paper
• The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.

  1997cited by this paper
• A novel nuclear structure containing the survival of motor neurons protein.

  1996cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper

• Insights into spinal muscular atrophy from molecular biomarkers

  2024cites this paper
• Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy

  2023cites this paper
• Thirty years of translational research in Mobility Medicine: Collection of abstracts of the 2020 Padua Muscle Days

  2020cites this paper
• Spontaneous evolution of human skin fibroblasts into wound-healing keratinocyte-like cells

  2019cites this paper
• A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein

  2018cites this paper
• Method for analyzing expression of smn protein nuclear body

  2017cites this paper
• Imaging Flow Cytometry Analysis to Identify Differences of Survival Motor Neuron Protein Expression in Patients With Spinal Muscular Atrophy.

  2016cites this paper
• A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls

  2016cites this paper